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Leuthold S, Hagenbuch B, Mohebbi N, Wagner CA, Meier
PJ, Stieger B. Mechanisms of pH-gradient driven transport medi-
ated by organic anion polypeptide transporters. Am J Physiol Cell
Physiol 296: C570 –C582, 2009. First published January 6, 2009;
doi:10.1152/ajpcell.00436.2008.—Organic anion transporting polypep-
tides (humans OATPs, rodents Oatps) are expressed in most mammalian
tissues and mediate cellular uptake of a wide variety of amphipathic
organic compounds such as bile salts, steroid conjugates, oligopeptides,
and a large list of drugs, probably by acting as anion exchangers. In the
present study we aimed to investigate the role of the extracellular
pH on the transport activity of nine human and four rat OATPs/
Oatps. Furthermore, we aimed to test the concept that OATP/Oatp
transport activity is accompanied by extrusion of bicarbonate. By
using amphibian Xenopus laevis oocytes expressing OATPs/Oatps
and mammalian cell lines stably transfected with OATPs/Oatps,
we could demonstrate that in all OATPs/Oatps investigated, with
the exception of OATP1C1, a low extracellular pH stimulated
transport activity. This stimulation was accompanied by an in-
creased substrate affinity as evidenced by lower apparent Michae-
lis-Menten constant values. OATP1C1 is lacking a highly con-
served histidine in the third transmembrane domain, which was
shown by site-directed mutagenesis to be critically involved in the
pH dependency of OATPs/Oatps. Using online intracellular pH
measurements in OATP/Oatp-transfected Chinese Hamster Ovary
(CHO)-K1 cells, we could demonstrate the presence of a 4,4-
diisothiocyanatostilbene-2,2-disulfonic acid-sensitive chloride/bi-
carbonate exchanger in CHO-K1 cells and that OATP/Oatp-medi-
ated substrate transport is paralleled by bicarbonate efflux. We
conclude that the pH dependency of OATPs/Oatps may lead to a
stimulation of substrate transport in an acidic microenvironment
and that the OATP/Oatp-mediated substrate transport into cells is
generally compensated or accompanied by bicarbonate efflux.
anion/bicarbonate exchange
ORGANIC ANION TRANSPORTING polypeptides (rodents: Oatps; hu-
mans: OATPs) constitute a superfamily of sodium-independent
membrane transporters belonging to the solute carrier organic
anion transporter gene family Slco/SLCO (14). All Oatps/
OATPs are putative 12 transmembrane domain glycoproteins
with apparent molecular masses between 70 to 90 kDa and
are generally expressed in multiple organs. However, some
OATPs/Oatps are preferentially, if not exclusively, expressed
in the liver (e.g., rat Oatp1b2, OATP1B1, OATP1B3), where
they are expressed at the basolateral plasma membrane of
hepatocytes (5, 24, 25). In hepatocytes, they mediate uptake of
amphipathic albumin-bound compounds that are destined for
biotransformation and/or biliary excretion (14, 24). Others are
expressed in the brain [OATP1C1, OATP3A1_v1 and v2 (17,
44)] or more specifically in the blood-brain barrier [Oatp1a4
and OATP1A2 (10, 11)]. Functionally, Oatps/OATPs transport
in a sodium-independent manner a wide variety of amphipathic
organic compounds, including bile salts, steroid conjugates,
thyroid hormones, certain oligopeptides, and numerous drugs
(14, 26). So far, detailed knowledge on the transport mecha-
nism of OATPs/Oatps is missing, but evidence for a role of
bicarbonate as counterion and/or for pH-sensitive uptake with
transport stimulation by lower extracellular pH compared with
intracellular pH has been presented for rat Oatp1a1 and
Oatp1b2 (35, 54) as well as OATP2B1 (23), suggesting an
organic anion/OH (or HCO3) exchange mechanism. Alter-
nately, substrate exchange for glutathione was demonstrated
for Oatp1a1 (32) and glutathione or glutathione conjugates for
rat Oatp1a4 (33). Hence, whereas the exact transport mecha-
nism for OATPs/Oatps remains elusive, the current evidence
suggests that they act as organic anion exchangers.
In the present study, we tested the hypothesis that stimula-
tion of the transport activity of OATPs/Oatps by a low extra-
cellular pH is a general phenomenon and that this stimulation
of transport may be followed by an increase of OATP/Oatp-
mediated bicarbonate efflux. We observed that with the excep-
tion of OATP1C1, all tested OATPs/Oatps displayed an in-
creased transport activity at an inwardly directed pH gradient
in both Xenopus laevis oocytes and mammalian cell lines
stably transfected with OATPs/Oatps. Site-directed mutagene-
sis demonstrated that the absence of a highly conserved His in
the third transmembrane domain of OATP1C1 was responsible
for the lack of pH sensitivity of OATP1C1. Finally, we could
demonstrate for selected OATPs/Oatps, substrate transport
mediated bicarbonate efflux from stably transfected Chinese
Hamster Ovary (CHO)-K1 cells.
MATERIALS AND METHODS
Materials. [3H(G)]taurocholate (TC, 1.19 Ci/mmol, 3.5 Ci/mmol),
[6,7-3H(N)]estrone-3-sulfate (E3S, 57.3 Ci/mmol), [5,6,8,11,12,14,15-
3H(N)]prostaglandin E2 (PGE2, 200 Ci/mmol), and L-[125I]thyroxine
(T4, 969 Ci/mmol) were purchased from Perkin-Elmer Life Sciences
(Boston, MA). [2-3H]TC (50 Ci/mmol) was additionally obtained
from American Radiolabeled Chemicals (St. Louis, MO). Cell culture
media and reagents were obtained from Invitrogen (Carlsbad, CA).
4,4 -Diisothiocyanatostilbene-2,2 disulfonic acid disodium salt
(DIDS) was purchased from Sigma (St. Louis, MO). All other chem-
icals and reagents were of analytical grade and were readily available
from commercial sources.
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Animals. Female X. laevis were purchased from the African Xeno-
pus facility, Noordhoek, R. South Africa. The animals were kept
under standard conditions in accordance with the rules of the local
animal protection committee and with the federal guidelines, and the
protocols of the animal experiments were approved by the local
supervisory board on animal experimentation.
Subcloning of rat Oatp1b2 and OATP1B3. To isolate the rat
Oatp1b2 open reading frame (ORF), the original construct (4) was cut
with SalI and HindII. The DNA fragment was blunted using T4 DNA
polymerase (Fermentas, St. Leon-Rot, Germany), and the Oatp1b2
ORF was gel purified from a 0.8% agarose gel using the QIAquick
Gel Extraction kit (QIAGEN, Hilden, Germany). The pcDNA5/FRT
vector (Invitrogen, Carlsbad, CA) was linearized with EcoRV, de-
phosphorylated with calf intestine alkaline phosphatase (CIAP, Fer-
mentas), and purified with QIAquick PCR purification kit (QIAGEN).
The isolated insert was ligated into the pcDNA5/FRT vector using the
Rapid DNA Ligation Kit (Roche Diagnostics, Mannheim, Germany).
The orientation and DNA sequence of the construct was verified by
sequencing.
The cDNA of OATP1B3 (31) was used to PCR amplify the
OATP1B3 open reading frame (ORF) by Pfu-polymerase (Stratagene,
La Jolla, CA) using the forward primer 5-ACGTACGCTAGCCAC-
CATGGACCAACATCAACATTTG-3 and the reverse primer 5-
CATGCAGCGGCCGCTTAGTTGGCAGCAGCATTG-3. The for-
ward primer included a NheI restriction site and the Kozak consensus
sequence (28) for optimal expression. The reverse primer contained a
NotI restriction site. The PCR amplified and restriction digested
fragment was gel purified and ligated with the Rapid DNA Ligation
Kit into the NheI/NotI sites of the gel purified, linearized pIRESneo2
vector (Clontech-Takara Bio Europe, Saint-Germain-en-Laye,
France). The sequence of the whole ORF was confirmed by DNA
sequencing.
Site-directed mutagenesis of Oatp1a1 and OATP1C1. The ORFs of
Oatp1a1 and OATP1C1 were isolated from pIRESneo2-Oatp1a1 and
pIRESneo2-OATP1C1 constructs (44) by digestion with NheI and
NotI. After gel purification, the inserts were ligated into the NheI/NotI
sites of the dephosphorylated pcDNA5/FRT vector. For mutagenesis
of the Oatp1a1 His107 and OATP1C1 Gln130, point mutations (Oatp1a1
H107Q and OATP1C1 Q130H) were introduced using the Quik-
Change Mutagenesis XLII Kit (Stratagene, La Jolla, CA). The NheI/
NotI fragments of the two mutagenized constructs were then again
ligated into the NheI/NotI sites of dephosphorylated pcDNA5/FRT
vector. The sequences of the whole ORF and the presence of the point
mutations were confirmed by DNA sequencing.
cRNA synthesis and expression in X. laevis oocytes. Oatp1a1,
Oatp1a4, Oatp1a5, Oatp1b2, OATP1A2, OATP1B1, OATP1B3,
OATP1C1, OATP2B1, OATP3A1_v1, OATP3A1_v2, OATP4A1, and
OATP4C1 cDNAs were available in our laboratory (4, 19, 30, 31, 40,
44). pCMV6-XL4 plasmid (Origene, Rockville, MD) containing ei-
ther OATP1B1, OATP1B3, OATP2B1, OATP4A1, or OATP4C1
cDNA was linearized with XbaI; pSPORT1 plasmid (Invitrogen,
Carlsbad, CA) containing Oatp1a1, Oatp1a4, Oatp1a5, Oatp1b2, or
OATP1A2 cDNA was linearized with NotI. OATP1C1, OATP3A1_v1, or
OATP3A1_v2 in the X. laevis expression vector (4) (pSPORT1 that
contains the initiation codon and the 5 as well as the 3-UTR of
Oatp1a1 for efficient stability and expression of the cRNA) were
linearized with NotI. Capped cRNA was synthesized using the
mMESSAGE mMACHINE T7 kit (Ambion, Austin, TX). X. laevis
oocytes were prepared by liberase digestion as previously described
(15). After an overnight incubation at 18°C, healthy oocytes were
microinjected with 50 nl water or with 5 ng cRNA in the same volume
and kept in culture at 18°C for 3 days with daily change of medium
before uptake of radiolabeled substrates was measured.
Transport assay in X. laevis oocytes. Uptake of radiolabeled
substrates was measured at 25°C in 100 l of uptake buffer (in mM:
100 NaCl or 100 choline chloride, 2 KCl, 1 MgCl2, 1 CaCl2, and 10
HEPES adjusted to pH 6.5 or 8.0 with Tris) as detailed in Reichel
et al. (47). In brief, 10 to 12 oocytes were prewashed in uptake buffer
and incubated for 20 min in the same solution containing the radio-
labeled substrate. After the oocytes were rinsed three times with
ice-cold uptake buffer without radiolabeled substrate, oocytes were
dissolved in 10% SDS for 3H-labeled substrates, 4 ml of scintillation
liquid (Ultima Gold; Perkin-Elmer, Boston, MA) was added, and
radioactivity was measured in a Packard Tri-Carb 2200 CA liquid
scintillation analyzer (Canberra Industries, Meriden, CT). [125I]T4
was measured in intact oocytes in a Packard Cobra QC Auto-Gamma
Counter (Canberra Industries).
Stably transfected cells. CHO-K1 and Madin-Darby Canine Kidney
(MDCK) cells stably transfected with rat Oatp1a1, OATP1B3,
OATP1C1, OATP2B1, or rat Oatp1a5 were previously described (6,
13, 44, 45, 60, 62). CHO-K1 cells were grown in DMEM supple-
mented with 10% FCS, 50 g/ml L-proline, 100 U/ml penicillin, and
100 g/ml streptomycin. Selective medium for stably transfected
CHO-K1 cells contained additionally 500 g/ml geneticin sulfate
(G418). MDCK cells stably expressing Oatp1a5 were kindly provided
by Dr. Paul A. Dawson [Wake Forest University, NC (62)]. They
were maintained in DMEM supplemented with 10% FCS, 100 U/ml
penicillin, and 100 g/ml streptomycin, whereas selective medium
contained additionally 350 g/ml G418 (62). CHO FlpIn cells (FlpIn
CHO-K1) were grown in Ham’s F12 medium supplemented with 10%
FCS, 1 mM L-glutamine, and zeocin (100 g/ml). All cells were kept
at 37°C with 5% CO2 and 95% relative humidity.
FlpIn CHO-K1 cells stably transfected with rat Oatp1a1, Oatp1a1
H107Q, rat Oatp1b2, OATP1C1, and OATP1C1 Q130H were gener-
ated using the FlpIn recombinase-mediated system kit (Invitrogen,
Carlsbad, CA), which permits the targeted integration of genes to the
same locus in all transfected cells to provide a homogeneous level of
gene expression. FlpIn CHO-K1 were cotransfected with the Oatp/
OATP-containing plasmid and pOG44 that encodes the Flp recombi-
nase by treatment with Lipofectamine 2000 (Invitrogen), and stably
transfected cells were selected with hygromycin (500 or 600 g/ml).
In the case of stably transfected rat Oatp1a1-, Oatp1a1 H107Q-,
OATP1C1-, and OATP1C1 Q130H-CHO FlpIn cells, single clones
were isolated from the resulting transfected cell pools by limited
dilution and tested for E3S or T4 uptake. Clones exhibiting the highest
transport activities were expanded and used in all experiments.
Transport assays in cells. Determination of substrate uptake into
Oatp/OATP expressing CHO-K1 and MDCK cells was performed as
described (6, 55, 62). Briefly, cells were grown to confluency on
35-mm dishes. Expression of Oatp/OATP was induced by incubation
of the cells for 24 h with culture medium supplemented with 5 mM
(CHO-K1 cells) or 10 mM (MDCK cells) sodium butyrate (43). At the
day of the experiment, CHO-K1 cells on individual dishes were rinsed
two times with prewarmed (37°C) uptake buffer (in mM: 116 choline
chloride, 5.3 KCl, 1.1 KH2PO4 or NaH2PO4, 0.8 MgSO4, 5.5
D-glucose, and 20 HEPES), whereas MDCK cells were rinsed with
prewarmed PBS. Uptake experiments were performed in the uptake
buffer (CHO-K1 cells) or in Hanks’ balanced salt solution (for MDCK
cells, in mM: 137 NaCl, 5.3 KCl, 0.46 KH2PO4, 0.27 Na2HPO4, 5.5
D-glucose, and 4.17 NaHCO3) containing 0.15 Ci/ml ([125I]thyrox-
ine) or 0.2 to 1.2 Ci/ml (3H-labeled compounds) radiolabeled sub-
strate supplemented with unlabeled compound to reach the indicated
concentrations. Transport was stopped with 2 ml of ice-cold uptake
buffer (CHO-K1) or PBS (MDCK) followed by two additional
washes. Thereafter, cells were solubilized in 1 ml of 1% (wt/vol)
Triton X-100 (CHO-K1) or 0.1 M NaOH (MDCK), and the radioac-
tivity was measured by liquid scintillation counting. Protein concen-
trations on individual dishes were determined using the bicinchoninic
acid protein (BCA) assay kit (Interchim, Montluc¸on Cedex, France)
(56). Specific Oatp/OATP-mediated uptake was determined by sub-
tracting values from identical experiments conducted in wild-type or
mock-transfected cells.
For the inhibition experiments with acetazolamide and amiloride,
these compounds were added to the uptake buffers as indicated in
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Figure 6. To test the influence of the histidine-specific reagent dieth-
ylpyrocarbonate (DEPC) (16) on transport, CHO-K1 cells grown on
35-mm dishes were first washed twice with prewarmed uptake buffer
of pH 7.4, incubated with different concentrations of DEPC in the
uptake buffer (control without DEPC) for 10 min at 37°C and 5%
CO2, followed by the uptake procedure outlined above.
For kinetic analysis, the Michaelis-Menten constant (Km) and
maximal velocity (Vmax) was calculated using nonlinear regression
analysis (Systat Version 8.0, SPSS, Chicago, IL).
pHi measurements. For intracellular pH (pHi) measurements in
CHO-K1 cells, the cells were grown to subconfluency on glass
coverslips. For the duration of the experiment, they were kept in a
thermostatically controlled chamber maintained at 37°C on an in-
verted microscope (Zeiss Axiovert 200) equipped with a video imag-
ing system (64). The cells were incubated for 10 min with 10 M of
the pH-sensitive dye 2,7-bis-(2-carboxyethyl)-5-(and 6)-carboxy-
fluorescein (BCECF)-AM (48) (Invitrogen) in a HEPES-buffered
Ringer solution (in mM: 125 NaCl, 5 KCl, 1 CaCl2, 1.2 MgSO4, 2
NaH2PO4, 32.2 HEPES, and 5 D-glucose, pH 7.4) at 37°C. For data
presented in Fig. 5, A and B, wild-type CHO-K1 cells were then
washed with buffer A (HCO3 containing/Cl containing; see Table 1)
to remove extracellular non-deesterified BCECF-AM and to achieve a
stable baseline, followed by buffer B (HCO3 free/Clfree) to induce
an intracellular alkalinization. For one batch of cells, buffer C (HCO3
free/Cl containing) was added after the intracellular alkalinization to
recover pHi. For data presented in Fig. 5C, wild-type CHO-K1 cells
were rinsed with buffer A (HCO3 containing/Cl containing; see
Table 1) until a stable baseline was achieved, followed by superfusion
with buffer D (HCO3 containing/Cl free; see Table 1) to induce
intracellular alkalinization. Thereafter, cells were again superfused
with buffer A. After completion of this incubation sequence, the same
cells were again subjected to the described buffer changes, but all
buffers were supplemented with 100 M DIDS. For experiments
shown in Fig. 7, cells were washed with buffer B (HCO3 free/Cl
free) or buffer D (HCO3 containing/Cl free) after the BCECF-AM
incubation. Both buffers contained additionally 0.1 mM acetazol-
amide, an inhibitor of the enzyme carbonic anhydrase (CA), and 1
mM of the sodium-proton exchanger inhibitor amiloride. After wash-
ing was completed, cells were superfused with the respective buffers
for 10–15 min in the absence of any transporter substrates to obtain a
stable baseline. E3S or TC (100 M) were then added to the respec-
tive buffers, and cells were superfused for 10 min to activate
transport. During all experiments, cells were alternately excited at 490
and 440 nm, whereas the fluorescence emission was recorded at 535
nm every 5 s. The resulting 490/440 intensity ratio data were con-
verted to pHi by using the high K/nigericin calibration technique
(50, 64). In brief, at the end of each experiment, an in situ
calibration procedure with nigericin, a H/K exchanger, was
used to relate the fluorescence intensities to pH value. This H/K
exchanger ionophore sets [K]o  [K]i and pHo  pHi by
exposing the cells to different pH buffers in a depolarizing high K
buffer (105 mM KCl, 1.2 mM MgSO4, 32.8 mM N-methyl-D-
glucamine, 1 mM CaCl2, 32.2 mM HEPES, pH 6.5 and pH 7.0, in
the presence of 10 M nigericin).
Initial slopes after the addition of the substrates were calculated,
and data were expressed as acidification (pHi/min) or alkalinization
(pHi/min) rates, respectively. pHi of 19 single cells was recorded
per experiment, and all experiments repeated with at least four batches
of cells (total of 67–136 cells).
Statistical analysis. Values are shown as means  SD (Figs. 1, 3,
4, 6) or as means  SE (Fig. 7, Table 2). In transport experiments,
statistical significance was determined by an unpaired Student’s t-test.
For comparison of Km and Vmax values in Table 2, a paired Student’s
t-test was performed when more than three experiments were done,
whereas in the case of single or duplicate experiments, 95% confi-
dence intervals are given in parenthesis. The software program Graph-
Pad Prism Version 4.00 was used for nonlinear regression and
statistical analysis (GraphPad Software, San Diego, CA).
RESULTS
Effect of extracellular pH on Oatp/OATP-mediated sub-
strate transport. First, the effect of the extracellular pH on the
transport activity of four rat Oatps and nine human OATPs
expressed in X. laevis oocytes was investigated. For this, we
chose the two prototypical substrates TC and E3S, which are
transported by most Oatps/OATPs, and their uptake was mea-
sured in extracellular buffers of pH 6.5 and pH 8.0. Because
some human OATPs are known to exhibit only low TC- or
E3S-transport activity, we measured in addition uptake of
PGE2 (17, 57) and T4 for some additional OATPs (8, 37, 44).
All rat Oatps as well as human OATP1A2 and 1B3 displayed
statistically significantly increased TC transport at extracellular
pH 6.5 compared with extracellular pH 8.0, whereas human
OATP1B1, OATP1C1, and all tested members of the OATP
families 2 to 4 did not reveal any stimulation of TC transport
at low extracellular pH (Fig. 1A). In contrast, E3S uptake at
extracellular pH 6.5 was enhanced in all investigated Oatps/
OATPs with the exception of the human OATP1B1 (Fig. 1B).
For PGE2, we observed significantly higher transport activity
at extracellular pH 6.5 compared with pH 8.0 in all studied rat
Oatps and human OATP1A2 and OATP1B1. Interestingly,
also OATP1C1, OATP2B1, and OATP3A1_v1/_v2 tended
toward increased PGE2 transport at extracellular pH 6.5 (Fig.
1C). When T4 was used as substrate, uptake was stimulated in
all investigated Oatps/OATPs with the exception of rat
Oatp1b2 and human OATP1C1 (Fig. 1D). It is interesting to
note that with none of the substrates tested in Fig. 1, OATP1C1
displayed significant pH-sensitive transport activity, indicating
that OATP1C1 has a transport mechanism different from the
other OATPs/Oatps investigated. The activation of Oatp/
OATP-mediated transport at low extracellular pH suggests
either an Oatp/OATP-mediated transport associated with
HCO3 (or OH) exchange or with H cotransport. This
should be reflected by a difference in Vmax values at the two
different pHs. Alternately, substrate binding to the transporter
might be pH sensitive, which in turn would lead to a pH
dependency of the respective apparent Km values.
Table 1. Composition of buffers for pHi measurements
Buffer
A B C D
KCl 5.3 5.3
K-gluconate 5.3 5.3
NaH2PO4  H2O 1 1 1 1
MgSO4  7H2O 0.8 0.8 0.8 0.8







CO2, % 5 5
O2, % 95 95
pH 7.4 7.4 7.4 7.4
All solute concentrations are given in millimolar.
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Therefore, we next determined the Michaelis-Menten pa-
rameters at extracellular pH 6.5 and pH 8.0 for E3S, TC, PGE2,
and T4 for selected rat and human Oatps/OATPs stably ex-
pressed in CHO-K1 and MDCK cells. In pilot experiments
initial linear uptake rates of 15 s for OATP/Oatps in stably
transfected CHO-K1 cells and of 1 min for rat Oatp1a5
expressed in MDCK cells were determined (data not shown).
We found that with the exception of OATP1C1-mediated
T4-uptake, all investigated Oatps/OATPs showed a tendency to
decreased apparent Km values at extracellular pH 6.5 compared
with extracellular pH 8.0, whereas the Vmax values remained
unaffected (Table 2). Statistical analysis showed that the ap-
parent Km values for Oatp1a1-mediated E3S and TC uptake are
significantly decreased at extracellular pH 6.5 compared with
pH 8.0, whereas the Vmax values exhibited no significant
differences between pH 6.5 and H 8.0 (Table 2).
Lower Km values at acidic pH may be due to a higher affinity
of the substrate to the respective transporter, which in turn may
depend on the protonation state of the substrate used or on
pH-dependent alterations of the binding site of the transport
protein. To this end, it is interesting to note that one highly
conserved histidine residue (His), which is located at the
extracellular side of the third transmembrane domain (TMD),
is replaced by a glutamine (Gln) residue in OATP1C1 (Fig. 2).
Histidine has a pKa of 6.9 in proteins (38). Therefore, it is
likely that lowering the extracellular pH from 8.0 to 6.5 leads
to protonation of the imidazole ring and consequently to the
addition of a positive charge to this conserved His (Fig. 2) in
the analyzed Oatps/OATPs.
Influence of DEPC on transport activities of Oatps/OATPs.
To investigate whether this conserved His in the third TMD
(Fig. 2) indeed plays a role in the pH dependency of Oatp/
OATP-mediated transport, uptake experiments in stably
transfected CHO-K1 cells were performed in the absence
and presence of the His-specific reagent DEPC (38). For this
purpose, CHO-Oatp1a1, -Oatp1b2, -OATP2B1, and -OATP1C1
cells were preincubated for 10 min with different concentra-
tions of DEPC or buffer only, followed by uptake measure-
ments at 1 min using extracellular buffers of pH 6.5 and 8.0,
respectively. Figure 3 shows that the pH dependency in the
case of Oatp1a1- (Fig. 3A), Oatp1b2- (Fig. 3B), and
OATP2B1-mediated (Fig. 3C) E3S uptake was gradually re-
duced or even abolished with increasing DEPC concentrations
at both pH values. OATP1C1-mediated T4 uptake in contrast
was not affected by DEPC at pH 6.5 (Fig. 3D), whereas at pH
8.0 the lowest concentration of 0.5 M DEPC led to an
inhibition of uptake by 55%, which remained constant at this
level at higher DEPC concentrations. The sensitivity of
OATP1C1 to DEPC at pH 8.0 is most likely due to the
presence of additional His residues. In OATP1C1, H260 and
H468 probably also face the extracellular milieu (14). The
distinct DEPC sensitivity of OATP1C1 at acidic pH further
supports the hypothesis that the conserved His in the third
TMD might be involved in the pH-sensitive transport but does
Table 2. pH dependency of Michaelis-Menten parameters of OATPs/Oatps
Substrate
pH 8.0 pH 6.5
nKm, M Vmax, pmol/mg protein  min1 Km, M Vmax, pmol/mg protein  min1
Oatp1a1
CHO
E3S 39.04.3*) (30.3 to 47.6) 1,68968.3 (1,553 to 1,826) 20.42.7*) (14.9 to 25.8) 1,52963.4 (1,402 to 1,655) 4
TC 79.417.0*) (45.5 to 113) 71058 (594 to 827) 31.76.4*) (19.0 to 44.4) 61737.5 (542 to 692) 5
Oatp1a5
MDCK
E3S 177124 (81.1 to 434) 45398.1 (250 to 657) 83.545.0 (9.85 to 177) 38350.4 (278 to 487) 2
TC 18.23.0 (11.7 to 24.70) 46.62.9 (40.3 to 52.9) 8.52.8 (2.55 to 14.5) 55.15.43 (43.4 to 66.8) 1
PGE2 10818.8 (69.1 to 148) 98.2 to 9.22 (78.9 to 117) 56.811.5 (32.4 to 81.3) 85.18.7 (66.6 to 104) 1
Oatp1b2
CHO
E3S 91.717.3 (57.2 to 126) 2,332206 (1,920 to 2,744) 56.115.3 (25.5 to 86.6) 2,164232.5 (1,699 to 2,628) 5
TC 41.19.8 (20.7 to 61.5) 47555.7 (360 to 591) 22.35.71 (10.5 to 34.2) 40743.8 (316 to 498) 2
PGE2 20.05.57 (8.56 to 31.5) 20526.1 (151 to 259) 9.572.94 (3.50 to 15.6) 23026.1 (176 to 284) 2
OATP1B3
CHO
E3S 73.024.6 (23.7 to 122) 1,776370 (1,036 to 2,517) 54.67.62 (39.3 to 69.8) 1,798133.3 (1,532 to 2,065) 3
OATP1C1
CHO
T4 0.180.04 (0.10 to 0.26) 22.01.91 (18.2 to 25.9) 0.270.07 (0.13 to 0.40) 37.84.72 (28.2 to 47.4) 2
OATP2B1
CHO
E3S 17.82.92 (11.8 to 23.8) 1,400114 (1,167 to 1,633) 9.360.93 (7.46 to 11.3) 1,29351.13 (1,187 to 1,398) 2
T4 0.770.18 (0.40 to 1.15) 7.281.10 (5.04 to 9.51) 0.310.09 (0.13 to 0.50) 5.760.80 (4.13 to 7.39) 2
Values are means  SE of 1–5 individual determinations (n). 95% confidence intervals are given in parentheses. Oatps, rodent organic anion transporting
polypeptide; OATPS, human organic anion transporting polypeptide; CHO, chinese hamster ovary; MDCK, Madin-Darby canine kidney cells; E3S,
estrone-3-sulfate; TC, taurocholate; PGE, prostaglandin E2; T4, thyroxine; Km, Michaelis-Menten constant; Vmax, maximal velocity. Wild-type CHO-K1 resp.
MDCK cells or stably transfected CHO-Oatp1a1, -Oatp1b2, -OATP1B3, -OATP1C1, -OATP2B1, or MDCK-Oatp1a5 cells were grown to confluency on 35-mm
dishes. After a 24-h incubation in 5 mM (CHO) or 10 mM (MDCK) sodium butyrate, the cells were incubated with increasing concentrations of radiolabeled
substrates at 37°C for 15 s (CHO) resp. 1 min (MDCK) in a choline chloride medium. The net Oatp/OATP-mediated uptake values were calculated by
substracting the values obtained with the wild-type CHO-K1 resp. MDCK cells from those obtained with the stably transfected cells. Kinetic parameters were
calculated by fitting the data to the Michaelis-Menten (Km) equation with nonlinear regression. T4, thyroxine. Km values in bold and marked with an asterisk are
significantly different (P  0.05) between pH 6.5 and pH 8.0.
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not rule out a reaction of DEPC with other His residues present
in the investigated OATPs/Oatps.
Effect of the conserved His in the third TMD on pH-sensitive
Oatp1a1- and OATP1C1-mediated substrate transport. To
specifically assess the potential involvement of the conserved
His in the third TMD and to exclude an effect of other His
residues in pH-sensitive substrate transport by OATPs/Oatps,
mutants were generated by exchanging Gln130 to a His in
OATP1C1 (OATP1C1 Q130H) and His107 to a Gln in
Oatp1a1 (Oatp1a1 H107Q). These mutants and wild-type
Oatps/OATPs were stably expressed in FlpIn CHO-K1 cells,
and uptake experiments were performed at extracellular pH 6.5
and pH 8.0. The pH sensitivity of Oatp1a1-mediated substrate
transport (stimulation by 175  15.7% at pH 6.5 vs. pH 8.0;
Fig. 1. Effect of extracellular pH on organic anion transporting polypeptides (rodent) Oatp/OATP (human)-mediated substrate transport in Xenopus laevis
oocytes. Uptake of radiolabeled 5 M taurocholate (A), 0.5 M estrone-3-sulfate (B), 20 nM prostaglandin E2 (C), and 10 nM thyroxine (D) was measured for
20 min at 25°C as described under MATERIALS AND METHODS. Black bars, extracellular pH 6.5; open bars, extracellular pH 8.0. Results are expressed as means 
SD of 20–30 oocytes from 2–3 independent experiments (uptake values corrected for unspecific transport in water-injected oocytes). *P  0.05.
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P  0.01) disappeared in Oatp1a1 H107Q (Fig. 4A), whereas
OATP1C1 Q130H-mediated T4-uptake acquired pH sensitivity
(stimulation by 115  39.3% at pH 6.5 vs. pH 8.0; P  0.01)
in contrast to the wild-type OATP1C1 (Fig. 4B). This finding
is a strong indication for the involvement of this highly
conserved His in pH-sensitive substrate binding. These results
together with the DEPC inhibition experiments strongly sug-
gest that the highly conserved His in the third TMD plays a
crucial role in the pH sensitivity of the apparent Km values of
Oatps/OATPs.
Influence of extracellular chloride on pHi recovery of
CHO-K1 cells. Despite the role of a His in OATP/Oatp-
mediated transport, the results in Fig. 1 do not entirely exclude
a potential role of bicarbonate as a counterion for substrate
uptake. This assumption has been strongly supported for rat
Oatp1a1 (54), implying taurocholate/bicarbonate exchange.
Hence, we aimed to preload CHO-K1 cells transfected with
OATPs/Oatps with bicarbonate and to determine bicarbonate
efflux by online measurement of pHi changes (64). To this end,
we first verified the functional expression of a Cl/HCO3
Fig. 1.—Continued
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exchanger in CHO-K1 cells. The results in Fig. 5 demonstrate
a rapid increase of pHi after changing the incubation solution
from a buffer containing 107 mM Cl and 25 mM HCO3
(Table 1, buffer A, pH 7.4) after equilibrating the cells for 5–10
min to a HEPES-buffered HCO3 free/Cl free solution (Cl
replaced by gluconate; Table 1, buffer B, pH 7.4). This pro-
cedure led to a rapid intracellular alkalinization as a result of
the efflux of CO2 from the cells (Fig. 5A). The rate of pHi
recovery was very low with 0.0092  0.070 	pHi/min (n 
17). When extracellular Cl (122 mM) was added back to the
incubation solution, the rate of pHi recovery after the intracel-
lular alkalinization was increased to 0.0567  0.0041 	pHi/
min, n  19 (Fig. 5B; Table 1, buffer C, pH 7.4), which was
significant compared with the recovery rate in Fig. 5A (P 
0.01). Cl/HCO3 exchange is subject to inhibition by DIDS
(46, 49). Therefore, we tested the influence of DIDS on the
observed pHi recovery after alkalinization (Fig. 5B). Figure 5,
C and D, demonstrates that the pHi recovery rate (0.031 
0.0012) 	pH/min was significantly reduced in the presence of
DIDS [0.013  0.0008 	pH/min (P  0.01)]. Taken together,
these data clearly demonstrate the existence of a Cl/HCO3
exchanger in CHO-K1 cells, which could be used to load the
cells with HCO3.
Effect of amiloride and acetazolamide on Oatp/OATP-me-
diated transport activity. To eliminate any contribution to pHi
changes caused by CA or the sodium-proton exchanger (NHE)
expressed in CHO-K1 cells and consequently minimizing pHi
changes from OATP/Oatp-mediated bicarbonate efflux, we
added 0.1 mM acetazolamide, an inhibitor of CA (58), and 1
mM amiloride, an inhibitor of NHE (22, 51). To test a possible
interference of these two inhibitors with Oatp/OATP-mediated
substrate transport, uptake of TC and E3S in stably transfected
CHO-Oatp1a1 cells was measured in the absence and presence
of amiloride or acetazolamide. Figure 6 shows that amiloride
did not change transport activity for both substrates. In con-
trast, acetazolamide showed a significant inhibition of TC
uptake by 25.1  10.0% (P  0.05), whereas E3S uptake was
significantly stimulated by 19.4  3.2% (P  0.05). The effect
of acetazolamide was deemed to be too small to interfere with
the planned experiments, since the remaining transport activity
of Oatp1a1 with TC as substrate is still 75%.
Effect of Oatp/OATP-mediated substrate transport on pHi in
stably transfected CHO-K1 cells. pHi changes after the addi-
tion of TC or E3S were measured in wild-type and stably
transfected CHO-K1 cells. Cells were superfused with buffer D
(Table 1, HCO3 containing/Cl free) or buffer B (Table 1,
HCO3 free/Cl free) during the experiment. Figure 7A shows
acidification rates of wild-type and rat Oatp1a1-CHO cells
HCO3 preloaded or not preloaded in response to exposure to
100 M TC. pHi changes differed significantly between
HCO3-preloaded wild-type and stably transfected cells (P 
0.01), whereas pHi changes between not preloaded wild-type
and stably transfected cells were not significantly different
(P  0.18). After wild-type acidification rates were subtracted
from the values obtained from rat Oatp1a1-CHO cells, acidi-
fication rates of HCO3-preloaded cells were significantly
higher than acidification rates from unloaded cells (Fig. 7B;
P  0.01). These results are in line with the data from Satlin
and co-workers (54) and confirm that rat Oatp1a1 mediates
taurocholate/bicarbonate exchange. We went on to measure
acidification rates of HCO3-preloaded and not preloaded wild-
type and rat Oatp1a1-, OATP1B3-, and OATP2B1-CHO cells
after the addition of 100 M E3S. Figure 7, C–E, shows rates
of pHi changes of stably transfected cells after subtracting
wild-type values. In all investigated HCO3-preloaded cells,
acidification rates were significantly higher compared with
acidification rates in unloaded cells (Fig. 7, C–E; P  0.01).
Hence, the three OATPs/Oatps investigated mediate E3S/bi-
carbonate exchange.
DISCUSSION
Since detailed information on the driving force(s) and on the
transport mechanism(s) of Oatps/OATPs is scarce, we decided
to further investigate the role of the extracellular pH on the
transport activity of 11 rat and human Oatps/OATPs. These
experiments yielded three main findings. First, with the excep-
tion of OATP1C1, all investigated OATPs/Oatps displayed
increased transport activity for different substrates under con-
ditions of low compared with high extracellular pH. This
finding was paralleled by a decreased apparent Km value at low
extracellular pH. Second, OATPOs/Oatps have a conserved
His in the third TMD possibly facing the extracellular milieu.
This His residue is absent from the pH-insensitive OATP1C1,
which upon introduction of a His at position 130 turns into a
pH-sensitive transporter. Finally, substrate-meditated bicar-
bonate efflux was identified in all OATPs/Oatps documented
by online intracellular pH determinations.
The stimulation of Oatp/OATP-mediated transport by an
acidic extracellular pH was observed in both the amphibian X.
laevis oocytes and the mammalian CHO-K1 cell expression
systems (Fig. 1; Table 2). This observation clearly demon-
Fig. 2. Predicted 12 transmembrane domain model of an Oatp/OATP and
amino acid sequence comparison of investigated Oatps/OATPs. N-glycosyla-
tion sites (Y) are present on extracellular protein loops. The OATP superfamily
signature is indicated in grey at the border of the extracellular loop 3 and the
TMD 6.
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strates that stimulation of Oatp/OATP-mediated transport by
an extracellular pH is an intrinsic property of the transporters
and not related to the expression system used for transporter
characterization. This conclusion is further supported by pre-
vious studies of the effect of extracellular pH on Oatp/OATP-
mediated substrate transport in HeLa-Oatp1a1, CHO-Oatp1a1,
and HEK293-OATP2B1 cells using different approaches (20,
23, 34, 39, 42, 52, 54). Thus our data are in line with all these
studies showing an enhanced OATP/Oatp-mediated substrate
transport in the presence of a low extracellar pH. Of all the
OATPs/Oatps investigated, OATP1B1 showed no pH depen-
dency for TC and E3S, while transport of PE2 and T4 uptake
into X. laevis oocytes was stimulated by a low extracellular pH
(Fig. 1). This finding may be explained by the observation that
OATP1B1 has two binding sites for E3S wit apparent Km
values of 0.23 and 45 M, respectively, but only one for
fluvastatin (41). Thus it can be speculated that only one of the
two E3S binding sites is pH sensitive. This site could be the
binding site for T4 and PGE2. If this is the low-affinity E3S
binding site, we might have missed the pH dependency at the
E3S concentration used in our study. Marin and coworkers (34)
investigated the effect of different transmembrane pH gradients
on GC transport in stably transfected CHO-Oatp1a1 cells by
changing the intracellular pH with amiloride, NH4Cl, or im-
idazole. They also observed that GC uptake was higher in the
presence of an inwardly compared with an outwardly directed
H gradient. However, this stimulation was not proportional to
the magnitude of the gradient. These authors suggested that
changes in pHi triggers a modification of the protonation state
of intracellular domains of the transport protein and, therefore,
cause the changes in transport activity. Another study reported
that the proton ionophore FCCP caused a significant reduction
of OATP2B1-mediated E3S uptake at acidic extracellular pH
in HEK-293 cells, suggesting that a proton gradient could be a
driving force for OATP2B1 (42). Sai and coworkers (52)
expressed OATP2B1 in HEK-293 cells and demonstrated that
an inwardly directed pH gradient enhanced transport of E3S
into vesicles isolated from these cells.
Changing the extracellular pH of an expression system can
either affect the protonation state and consequently the charge
of the substrate and/or the substrate binding pocket of the
transporter investigated. Our kinetic analysis of Oatp/OATP-
mediated substrate transport in stably transfected CHO-K1 and
MDCK cells revealed that extracellular low pH leads to an
increase of the apparent affinity (decreased Km value) with no
marked effect on Vmax for all Oatps/OATPs studied except for
OATP1C1 (Table 2). Whereas only the data for Oatp1a1
reached statistical significance, all other OATPs/Oatps (with
the exception of OATP1C1) showed an increase in apparent
affinity. Hence, we conclude that this pH dependency of
Fig. 3. Influence of diethylpyrocarbonate (DEPC) on transport activities of Oatps/OATPs in stably transfected CHO-K1 cells. Oatp1a1-mediated (A),
Oatp1b2-mediated (B), and OATP2B1-mediated uptake of 0.5 M estrone-3-sulfate(C), as well as OATP1C1-mediated uptake of 10 nM thyroxine (D) was
determined after 10 min preincubation with increasing concentrations of DEPC or buffer only. Squares, extracellular pH 6.5; triangles, extracellular pH 8.0.
Uptake values are corrected for unspecific transport in untransfected CHO-K1 cells and represent means  SD of triplicate determinations. Representative
experiments of 3 independent transport studies are shown.
C577pH DEPENDENCE OF ORGANIC ANION TRANSPORTING POLYPEPTIDES










apparent substrate affinities can be generalized for all investi-
gated transporters but OATP1C1. Similar results were also
obtained for the H gradient-dependent peptide transporter
PEPT1 in the small intestine, where lowering the extracellular
pH leads to a decreased Km while Vmax remains unchanged (27,
61). In contrast to our findings, it was demonstrated that an
acidic extracellular pH increases Vmax without affecting Km of
OATP2B1-mediated E3S-transport in HEK293 cells (42).
However, these authors used different extracelluar pH settings
(pH 5.0 vs. pH 7.4) and different incubation times for pH 5.0
and pH 7.4, which could contribute to this divergent finding.
Furthermore, Marin and coworkers (34) observed that intracel-
lular acidification leads to a decrease in Vmax with no effect on
Km of Oatp1a1-mediated GC transport in CHO-K1 cells (34).
Marin and coworkers also used CHO-K1 cells, but they mod-
ified the intracellular pH using amiloride without changing the
extracellular pH (pHi 7.45/pHo 7.40 vs. pHi 7.30/pHo 7.40).
These different experimental settings might account for the
discrepancies to our data. However, when considering intrinsic
clearances, defined as Vmax/Km, our data are consistent with the
findings of both groups. Intrinsic clearances at extracellular pH
6.5 were, with the exception of OATP1C1-mediated T4-trans-
port, 1.4- to 2.7-fold higher compared with extracellular pH 8.0
in our study (data not shown). Nozawa et al. (42) observed a
4.4-fold higher intrinsic clearance at extracellular pH 5.0 to
extracellular pH 7.4, whereas Marin et al. (34) reported a
1.7-fold enhanced intrinsic clearance at intracellular pH 7.45
compared with intracellular pH 7.30.
The observed lower apparent Km values at extracellular pH
6.5 reflect an increased affinity of the substrate to the transport
protein. Because all tested substrates are predominantly present
in their anionic form with a constant negative charge under the
applied pH conditions, the protonation state of amino acids of
the binding site of the transporters could be changed. Since His
is an amino acid, which can alter the protonation state and
consequently the charge of its side-chain, we searched the
OATPs/Oatps for His residues near the extracellular side of the
predicted 12 TMD structure and found a highly conserved His
in the third TMD fulfilling this criterion (Fig. 2) His residues
are known to play an essential role in pH-sensitive transporters
(38). Interestingly, this His was absent from the third TMD of
OATP1C1, which does not display pH-sensitive substrate
transport. This fact in conjunction with the missing decrease of
Km in OATP1C1-mediated T4-uptake at extracellular pH 6.5
(Table 2), allowed to test the hypothesis that this His in the
third TMD might play an essential role in the pH sensitivity of
Oatp/OATP-mediated substrate transport. Indeed, both exper-
iments with transport in the presence of the His-modifying
chemical DEPC and with the introduction of a His into the
third TMD of OATP1C1 confirmed this hypothesis (Figs. 3
and 4). The significance of His residues was also shown for the
H gradient-dependent peptide transporters PepT1 and PepT2
in studies with renal and intestinal brush-border membrane
vesicles, where transport activity was severely impaired fol-
lowing incubation with DEPC (21, 29). Other examples in-
clude the Na/H exchanger (9, 12), the organic cation/H
antiporter (16) or the folate transporter (53). In all these
transporters, one or more individual His residue(s) were iden-
tified as important factors for transport activity (1, 7, 63).
Recently, structural models for OATP1B3 and OATP2B1 were
generated in silico, and a positively charged central pore was
identified (36). Around this putative core, highly conserved
single amino acid residues were found, which are thought to be
responsible for the positive charge of the pore and most
probably contribute to the substrate-binding site of the OATP1
and/or OATP2 family. Although no residue was identified to
be fully conserved throughout the OATP/SLCO superfamily, a
His in OATP2B1 was found to be conserved in all OATP2
family members. In the 12 TMD model of Oatps/OATPs, this
His579 is located in TMD 10. As it is predicted to face the
pore, it is exposed to the extracellular medium and therefore
susceptible to pH changes of the medium. His92 in OATP1B3
is highly, although not fully conserved among the OATP1
family and also faces the central pore. Hence, this study
confirms that His residues play an important role in the sub-
strate-binding sites of Oatps/OATPs. In addition, Meier-Abt
et al. (36) selected in their study the large extracellular loop
9–10 for a structural modeling attempt and found that the
electrostatic potential of the loop is not positive. Therefore,
they suggested that it might not be involved in the attraction of
the substrate to the transporter but might cover the pore in the
Fig. 4. Effect of the conserved His in the third transmembrane domain on
pH-sensitive Oatp1a1- and OATP1C1-mediated transport in stably transfected
CHO-K1 cells. Uptake of 0.5 M estrone-3-sulfate (Oatp1a1, Oatp1a1
H107Q) (A) or 10 nM thyroxine (OATP1C1, OATP1C1 Q130H) (B) was
measured for 1 min at 37°C as described under MATERIALS AND METHODS. Solid
bars, extracellular pH 6.5; open bars, extracellular pH 8.0. Results are ex-
pressed as means  SD of triplicate determinations from 3 independently
performed transport studies. Uptake values are corrected for unspecific trans-
port in CHO-K1 cells and normalized to uptake at pH 8.0 ( 100%). Absolute
uptakes were for Oatp1a1: pH6.5: 30.9  10.9 pmol/mg protein  min, pH 8.0:
12.7  7.07 pmol/mg protein  min; for Oatp1a1 H107Q: pH 6.5: 2.84  1.27
pmol/mg protein  min, pH 8.0: 2.95  1.24 pmol/mg protein  min; for
OATP1C1: pH 6.5: 0.0917  0.0809 pmol/mg protein  min, pH 8.0: 0.0897 
0.0779 pmol/mg protein  min for OATP1C1 Q130H: pH 6.5: 0.33  0.146
pmol/mg protein  min, pH 8.0: 0.198  0.073 pmol/mg protein  min,
*P  0.01.
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absence of substrate, moving away after substrate binding.
Finally, investigations on the role of polymorphisms of OATPs
on OATP-mediated substrate transport revealed a clustering of
nonsynonymous polymorphisms in the third and fourth TMD
as well as the extracellular loop connecting these TMDs (26),
many of which lead to altered transport functions (65). These
findings highlight again a potential role of the third TMD and
its adjacent elements in OATP/Oatp-mediated substrate trans-
port. To the best of our knowledge, no polymorphisms of the
conserved His in the third TMD have been described so far,
which also supports the importance of this His in the transport
mechanism of OATPs/Oatps.
Increasing the extracellular H concentration will lead to a
conversion of HCO3 and H into H2O and CO2, causing an
outwardly directed HCO3 gradient across cell membranes.
This in turn might facilitate OATP/Oatp-mediated substrate
uptake into cells. Therefore, we investigated the capacity of
extracellular substrates of Oatps/OATPs to stimulate HCO3
efflux in stably transfected HCO3-loaded CHO-K1 cells. We
chose to monitor the intracellular pH online, which inversely
correlates with intracellular bicarbonate concentration. We
could demonstrate in CHO-K1 cells the presence of a Cl/
HCO3 exchanger (Fig. 5) and substrate induced bicarbonate
Fig. 5. Influence of extracellular chloride on pHi recovery in wild-type CHO-K1 cells. A: pHi recovery after acute intracellular alkalinization by CO2 efflux in
the absence of extracellular Cl. Cells were superfused with buffer A (HCO3 containing/Cl containing) for5 min, before the incubation buffer was exchanged
for buffer B (HCO3 free/Cl free). B: pHi recovery after acute intracellular alkalinization by CO2 efflux in the presence of extracellular Cl. After intracellular
alkalinization, buffer C (HCO3 free/Cl containing) was added to induce pHi recovery. C: influence of DIDS (100 M) on intracellular alkalinization rates. After
reaching a steady state, cellular alkalinization was started by HCO3 containing/Cl containing buffer (buffer D) first in the absence and then in the presence
of DIDS. D: effect of DIDS on intracellular alkalinization rates. Initial slopes after removal of chloride from the incubation solution were determined.
Alkalinization rates are given as (pHi/min) in means  SE as described under MATERIALS AND METHODS. Buffer conditions are indicated by the bars above the
figure. Solid indicates the presence, open indicates the absence of the respective anion. Representative tracings of pHi of individual cells are shown. *P  0.01.
Fig. 6. Effect of amiloride and acetazolamide on transport activity of Oatp1a1
in stably transfected CHO-K1 cells. Uptake of 10 M taurocholate and 0.5 M
estrone-3-sulfate was measured in the absence of any inhibitor (solid bars), in
the presence of 1 mM amiloride (shaded bars) or 0.1 mM acetazolamide (open
bars) for 30 s at 37°C as described under MATERIALS AND METHODS. Uptake
values are corrected for unspecific transport in CHO-K1 cells and normalized
to uptake without any inhibitor ( 100%). Results are expressed as means 
SD of triplicate determinations of 2 independently performed transport studies.
*P  0.05.
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efflux from OATP/Oatp expressing cells (Fig. 7). In the rat and
human liver, Oatp1a1, OATP1B3, and OATP2B1 are ex-
pressed at the basolateral membrane of hepatocytes (6, 24, 31,
47). pH homeostasis in hepatocytes is established by the
coordinate action of two acid extruders, the basolateral
Na/H exchanger and the Na-HCO3 symporter, and one
acid loader, the canalicular Cl/HCO3 exchanger (3). Al-
though the pHi of hepatocytes is kept at7.2 in a narrow range
(2) and therefore slightly more acidic than the portal blood
(7.4), the outward movement of HCO3 may be favored by the
outwardly directed HCO3 gradient established by the Na-
HCO3 symporter. In addition, the existence of an unstirred
water layer and a proton diffusion barrier in the Disse space,
which is located between the basolateral membrane and the
endothelial cell layer, was postulated (18). This proton diffu-
sion barrier is thought to be a stagnant layer that acts as a
diffusion barrier for proton transfer from the membrane surface
to bulk water and exhibits therefore a lower pH compared with
this bulk phase. The proton diffusion barrier in hepatocytes is
probably maintained by the extrusion of protons by the
Na/H exchanger, the negative electric field exerted by
anionic phospholipid head groups, the unstirred water layer,
and the existence of extracellular matrix proteins such as
fibronectin and collagen in the Disse space. In the small
intestine, the existence of a region in proximity to the apical
membrane of enterocytes with a lower pH compared with the
Fig. 7. Acidification rates in HCO3 pre-
loaded and unloaded Oatp1a1- (A–C),
OATP1B3- (D), OATP2B1-transfected
CHO-K1 (E) or wild-type CHO-K1 cells
induced by 100 M taurocholate (TC) (A–B)
or 100 M estrone-3-sulfate (E3S) (C–E).
Cells were superfused with a HCO3-
containing or HCO3-free buffer before TC
or E3S was added. Initial slopes after the
addition of the substrates were calculated,
and data were expressed as acidification
rates (pHi/min) in means  SE as de-
scribed under MATERIALS AND METHODS. In
A, solid bars indicate wild-type, open bars
indicated stably transfected Oatp1a1-CHO
cells. In B–E, differences in pHi/min be-
tween wild-type and stably transfected
CHO-K1 cells are shown for HCO3-
preloaded and unloaded cells. *P  0.01.
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bulk phase of the lumen of the gut is well established (59). This
region, which is known as the microclimate pH region, is
created by the diffusion barrier in the mucus layer, the glyco-
calix, and by proton secretion from the enterocytes, whereby
the transport systems involved are still a matter of debate (59).
Such local acidic pH microclimates in the liver and the small
intestine are likely to create an inwardly directed H gradient
and therefore could well stimulate under physiological condi-
tions transport activities of Oatps/OATPs expressed at these
sites.
In conclusion, in the present study we have demonstrated
that the transport activity of OATPs/Oatps is generally stimu-
lated by an acidic extracellular environment. Additionally,
OATP/Oatp substrate transport generally leads to stimulation
of bicarbonate efflux, further supporting the concept that
OATPsOatps act as anion exchangers. The pH dependency of
OATPs/Oatps is linked to a highly conserved His in the third
TMD, an area that is also involved in altered transport prop-
erties of polymorphic OATPs. Nevertheless, the exact identi-
fication of a substrate binding site(s) and/or other sites criti-
cally involved in substrate transport by OATPs/Oatps requires
further studies.
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